Ledger.Open graph →
SEC Form D · filed July 2, 2024

Eliem Therapeutics, Inc

Offering
$120.0M
Sold
$120.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Liam Ratcliffe · Wilmington, DEDirectorAndrew Levin · Wilmington, DEExec · DirectorLiam Ratcliffe · Wilmington, DEDirectorAoife Brennan · Wilmington, DEExec · DirectorAndrew Levin · Wilmington, DEExec · DirectorAdam Rosenberg · Wilmington, DEDirectorKarl Gorin · St. Helier, Y9DirectorStephen Thomas · Wilmington, DEDirectorOSL Storage VI Investment Co, LLC · Dallas, TXDirectorJudith Dunn · Wilmington, DEDirectorJudith Dunn · Wilmington, DEDirectorRyan Markowski · Wilton Manors, FLExec · DirectorMark G. Bertagnolli · La Jolla, CADirectorDouglas G. Wall · La Jolla, CAExecDanielle Bisson · St. Helier, Y9DirectorAdam Rosenberg · Wilmington, DEDirectorSimon Tate · Wilmington, DEDirectorNull Baceline Investments, LLC · Denver, CODirectorSimon Tate · Wilmington, DEDirectorValerie Morisset · Wilmington, DEExecStephen Thomas · Wilmington, DEDirectorTianyu G. Zhou · La Jolla, CAExec · DirectorAoife Brennan · Wilmington, DEExec · DirectorValerie Morisset · Wilmington, DEExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗